IPOs
-
Inside P&C’s morning summary of the key stories to get you up to speed fast. -
The executive – whose new venture wrote $230mn last year – is skeptical about the long-term future of MGAs in the D&O and casualty spaces.
-
Inside P&C’s news team runs you through the key developments from the week.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
Interested firms (and their PE backers) are eyeing multiple arbitrage, with Ryan Specialty and BRP trading at 24x versus private multiples of 15x-18x.
-
Two more vehicle tech companies face SPAC-related securities suits.
-
The division reported in a regulatory filing total 2021 premiums of $5.6bn and $3bn in policy fees.
-
Board members include the former CEO of Assurant and the chief legal officer of Stripe.
-
Inside P&C’s news team runs you through the key developments from the week.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
The specialty insurer’s premium income grew from $457mn in 2020 to $1.8bn in 2021, and $2.1bn including Lancer.
-
Investors are taking a second look at private valuations, as they realize that an IPO or a SPAC exit is no longer an attractive option in the short term.
Related
-
Aspen files F-1 with SEC confirming 2025 IPO optionality
December 11, 2024 -
The jammed PE conveyor belt: Broking’s $200bn+ of trapped capital
December 11, 2024 -
Aspen revs up IPO preparations again to give Q1 optionality
October 22, 2024 -
Accelerant rekindles IPO work with Q1 2025 launch target
September 23, 2024 -
Core Specialty sets wheels in motion on New York IPO
August 29, 2024